NCT06244498View on ClinicalTrials.gov

Tranexamic Acid After Pathological Fracture Treated With Modular Arthroplasty

CompletedOBSERVATIONAL
Enrollment

110

Participants

Timeline

Start Date

January 1, 2018

Primary Completion Date

December 31, 2021

Study Completion Date

December 31, 2022

Conditions
Metastases to Bone
Interventions
DRUG

Tranexamic acid injection

Tranexamic acid were administered at a dose of 1.0 g during the induction of anaesthesia and immediately after surgery.

Trial Locations (1)

36-200

SzSPOO Brzozów, Brzozów

All Listed Sponsors
lead

Piotr Biega

OTHER

NCT06244498 - Tranexamic Acid After Pathological Fracture Treated With Modular Arthroplasty | Biotech Hunter | Biotech Hunter